Market Research Reports

Drug Device Combination Products Market (Drug Eluting Stents, Infusion Pumps, Photosensitizers, Orthopedic Combination Products, Wound Care Combination Products, Inhalers, Transdermal Patches, Intraocular Implants and Drug Eluting Beads) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

117pages
Published Date: 2013-12-24
 

Description



Drug device combination products are defined as the individual products comprising of two regulated components, an active pharmaceutical ingredient and medical device that are chemically or physically combined to produce a single product. The drugs present in the device are either impregnated or surface coated. Combination products have emerged as innovative medical products due to their contribution in advancing medical care and are thus expected to have major impact on the overall medical devices market. 

This report covers the market analysis for various drug device combination products from the perspective of product types. The stakeholders for this report include the present manufacturers and providers of drug device combination products as well as the new players who desire to enter this market. This report comprises an executive summary, which provides the market snapshot covering overall information about the various segments and sub-segments of drug device combination products market. 

The market overview section of the report explains about the market dynamics and trends such as the drivers, restraints and opportunities that have an influence over current and future status of this market. Degree of competitiveness is explained through Porter’s five forces analysis and the most attractive regional market by type is represented in the market attractiveness analysis section of this report. All these factors will help the market players to decide about the business strategies and plans to be incurred in future for strengthening their position in the global market. 

The global drug device combination products market has been differentiated into eight segments based on the product types. The products analyzed in this study are the drug eluting stents, infusion pumps, bone graft implants, photodynamic therapy, wound care combination devices, inhalers, transdermal patches and others (intraoral implants and drug eluting beads). Depending on types, these products are further differentiated into sub segments. Drug eluting stents has been segmented into coronary stents and peripheral vascular stents. Orthopedic combination products market includes two sub segments namely antibiotic bone cement and bone graft implants. Infusion pumps has been segmented into implantable infusion pumps and ambulatory infusion pumps. Inhalers market is further classified into three segments namely nebulizers, metered dose inhalers and dry powder inhalers. Each of the above product segments and sub-segments are analyzed on the basis of market size in terms of USD million for the period 2011 - 2019 along with compounded annual growth rate (CAGR %) for the period, considering 2012 as the base year. 

Geographically, the drug device combination products market has been classified into four major segments namely, North America, Europe, Asia Pacific and Rest of the World. Market revenue for 2011 to 2012 and forecast for 2013 to 2019 for drug device combination products is analyzed in this report. This section also provides the CAGR % of each geographical region for the forecast period of 2013 to 2019. A competitive landscape, mapping all the market players and their respective market shares for 2012 are provided in this report for drug eluting stents and infusion pumps. A list of recommendations is also provided in this report to help market players in increasing their market share and new entrants in establishing their strong position in the market.

The report concludes with the company profile section which covers the key information such as company overview, financial overview, product portfolio, business strategies and recent developments about the major market players in the drug device combination products. Some of the major companies which are profiled in this report include Abbott Laboratories, Allergan, Inc., Alcon, Inc., Arrow International, Inc., Boston Scientific Corporation, CareFusion Corporation, Covidien PLC, C.R. Bard, Inc., Ethicon, Inc., Medline Industries, Inc., Medtronic, Inc., Mylan, Inc., Pinnacle Biologics, Inc., Stryker Corporation, Terumo Corporation, W.L. Gore & Associates, Inc. 

Table of Contents


Table of Contents

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Secondary Research
      1.3.2 Primary Research
      1.3.3 Statistical Models
      1.3.4 List of Abbreviations
      1.3.5 Assumptions and Stipulations

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Market Definition and Overview
3.2 Market Drivers
      3.2.1 Rise in aging population and consequent cases of chronic diseases worldwide
      3.2.2 Increasing demand for minimally invasive products
3.3 Market Restraints
      3.3.1 Infections from drug device combination products such as implants and associated product recalls
3.4 Market Opportunities
      3.4.1 Growth opportunities in emerging economies with high unmet needs
      3.4.2 Introduction of biodegradable technology based products
3.5 Porter’s Five Forces Analysis: Global Drug Device Combination Products Market
      3.5.1 Bargaining Power of Suppliers
      3.5.2 Bargaining Power of Buyers
      3.5.3 Threat of Substitutes
      3.5.4 Threat of New Entrants
      3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Drug Device Combination Products Market, by Types

Chapter 4 Global Drug Device Combination Products, by Type, Size and Forecast, 2011-2019 (USD Billion)
4.1 Introduction
      4.1.1 Global Drug Device Combination Products Market Revenue, 2011 - 2019 (USD Billion)
4.2 Drug Eluting Stents
      4.2.1 Global Drug Eluting Stents Market Revenue, 2011 - 2019 (USD Billion)
      4.2.2 Coronary Stents
               4.2.2.1 Global Coronary Drug Eluting Stents Market, 2011-2019 (USD Billion)
      4.2.3 Peripheral Vascular Stents
               4.2.3.1 Global Peripheral Vascular Drug Eluting Stents Market, 2011-2019 (USD Billion)
4.3 Infusion Pumps
      4.3.1 Global Infusion Pumps Market Revenue, 2011-2019 (USD Billion)
      4.3.2 Implantable Infusion Pumps
              4.3.2.1 Global Implantable Infusion Pumps Market Revenue, 2011-2019 (USD Billion)
      4.3.3 Ambulatory Infusion Pumps
      4.3.4 Global Ambulatory Infusion Pumps Market Revenue, 2011-2019 (USD Billion)
4.4 Photosensitizers
      4.4.1 Global Photosensitizers Market Revenue, 2011-2019 (USD Billion)
4.5 Orthopedic Combination Products
      4.5.1 Global Orthopedic Combination Products Market Revenue, 2011-2019 (USD Billion)
      4.5.2 Antibiotic Bone Cement
      4.5.3 Bone Graft Implants
4.6 Wound Care Combination Products
      4.6.1 Antibiotic Wound Care Products
      4.6.2 Global Wound Care Combination Products Market Revenue, 2011-2019 (USD Billion)
4.7 Inhalers
      4.7.1 Global Inhalers Market Revenue, 2011-2019 (USD Billion)
      4.7.2 Nebulizers
              4.7.2.1 Global Nebulizers Market Revenue, 2011-2019 (USD Billion)
      4.7.3 Metered Dose Inhalers
              4.7.3.1 Global Metered Dose Inhalers Market Revenue, 2011-2019 (USD Billion)
      4.7.4 Dry Powder Inhalers
             4.7.4.1 Global Dry Powder Inhalers Market Revenue, 2011-2019 (USD Billion)
4.8 Transdermal Patches
      4.8.1 Global Transdermal Patches Market Revenue, 2011-2019 (USD Billion)
4.9 Other Drug Device Combination Products
      4.9.1 Global Other Drug Device Combination Products Market Revenue, 2011-2019 (USD Billion)
      4.9.2 Intraocular Implants
      4.9.3 Drug Eluting Beads

Chapter 5 Global Drug Device Combination Products, by Geography, 2011 - 2019 (USD Million)
5.1 Overview
      5.1.1 Global Drug Device Combination Products Market, by Geography, 2011 - 2019 (USD Billion)
      5.1.2 Global Drug Device Combination Products Market, by Geography, 2012 and 2019 (%)
5.2 North America
      5.2.1 North America Drug Device Combination Products Market Revenue, 2011 – 2019 (USD Billion)
5.3 Europe
      5.3.1 Europe Drug Device Combination Products Market Revenue, 2011 – 2019 (USD Billion)
5.4 Asia-Pacific
      5.4.1 Asia-Pacific Drug Device Combination Products Market Revenue, 2011 – 2019 (USD Billion)
5.5 Rest of the World
      5.5.1 RoW Drug Device Combination Products Market Revenue, 2011 – 2019 (USD Billion)

Chapter 6 Competitive Landscape
6.1 Market Share Analysis: Global Drug Device Combination Products Market
      6.1.1 Methodology
      6.1.2 Market Share Analysis for the global drug eluting stents market, by key players, 2012
      6.1.3 Market share analysis for the global infusion pumps market, by key players, 2012

Chapter 7 Recommendations
7.1 Research and Development Initiatives
7.2 Converging Technologies to Yield Efficiencies
7.3 Mergers and Acquisitions to Improve Market Presence
7.4 Conducting Product Awareness Programs
7.5 Investing in Emerging Economies

Chapter 8 Company Profiles
8.1 Abbott Laboratories
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Allergan, Inc.
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Recent Developments
      8.2.5 Business Strategies
8.3 Alcon, Inc.
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Development
8.4 Arrow International, Inc.
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Business Strategies
      8.4.5 Recent Developments
8.5 Bausch & Lomb, Inc.
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product Portfolio
      8.5.4 Recent Developments
      8.5.5 Business Strategies
8.6 Boston Scientific Corporation
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Business Strategies
              8.6.4.1 Acquisitions
      8.6.5 Recent Developments
8.7 CareFusion Corporation
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategies
      8.7.5 Recent Developments
8.8 Covidien PLC
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Business Strategies
      8.8.5 Recent Developments
8.9 C.R. Bard, Inc.
      8.9.1 Company Overview
      8.9.2 Financial Overview
      8.9.3 Product Portfolio
      8.9.4 Business Strategies
      8.9.5 Recent Developments
8.10 Ethicon, Inc.
      8.10.1 Company Overview
      8.10.2 Financial Overview
      8.10.3 Product Portfolio
      8.10.4 Business Strategies
      8.10.5 Recent Developments
8.11 Medline Industries, Inc.
      8.11.1 Company Overview
      8.11.2 Financial Overview
      8.11.3 Product Portfolio
      8.11.4 Business Strategies
      8.11.5 Recent Developments
8.12 Medtronic, Inc.
      8.12.1 Company Overview
      8.12.2 Financial Overview
      8.12.3 Product Portfolio
      8.12.4 Business Strategies
      8.12.5 Recent Development
8.13 Mylan, Inc.
      8.13.1 Company Overview
      8.13.2 Financial Overview
      8.13.3 Product Portfolio
      8.13.4 Business Strategies
      8.13.5 Recent Developments
8.14 Pinnacle Biologics, Inc.
      8.14.1 Company Overview
      8.14.2 Financial Overview
      8.14.3 Product Portfolio
      8.14.4 Business Strategies
      8.14.5 Recent Developments
8.15 Stryker Corporation
      8.15.1 Company Overview
      8.15.2 Financial Overview
      8.15.3 Product Portfolio
      8.15.4 Business Strategies
8.16 Terumo Corporation
      8.16.1 Company Overview
      8.16.2 Financial Overview
      8.16.3 Product Portfolio
      8.16.4 Business Strategies
      8.16.5 Recent Development
8.17 W. L. Gore & Associates, Inc.
      8.17.1 Company Overview
      8.17.2 Financial Overview
      8.17.3 Product Portfolio
      8.17.4 Recent Developments

List of Figures

FIG. 1 Drug Device Combination Products - Market Segmentation
FIG. 2 Global Drug Device Combination Products, 2012, (USD Billion)
FIG. 3 Porter’s Five Forces Analysis: Global Drug Device Combination Products Market
FIG. 4 Market Attractiveness Analysis: Global Drug Device Combination Products Market, by Types
FIG. 5 Global Drug Device Combination Products Market Revenue, 2011 – 2019 (USD Billion)
FIG. 6 Global Drug Eluting Stents Market Revenue, 2011 – 2019 (USD Billion)
FIG. 7 Global Coronary Drug Eluting Stents Market, 2011-2019 (USD Billion)
FIG. 8 Global Peripheral Vascular Drug Eluting Stents Market, 2011-2019 (USD Billion)
FIG. 9 Global Infusion Pumps Market Revenue, 2011-2019 (USD Billion)
FIG. 10 Global Implantable Infusion Pumps Market Revenue, 2011-2019 (USD Billion)
FIG. 11 Global Ambulatory Infusion Pumps Market Revenue, 2011-2019 (USD Billion)
FIG. 12 Global Photosensitizers Market, 2011-2019 (USD Billion)
FIG. 13 Global Orthopedic Combination Products Market Revenue, 2011-2019 (USD Billion)
FIG. 14 Global Wound Care Combination Products Market Revenue, 2011-2019 (USD Billion)
FIG. 15 Global Inhalers Market Revenue, 2011-2019 (USD Billion)
FIG. 16 Global Nebulizers Market Revenue, 2011-2019 (USD Billion)
FIG. 17 Global Metered Dose Inhalers Market Revenue, 2011-2019 (USD Billion)
FIG. 18 Global Dry Powder Inhalers Market Revenue, 2011-2019 (USD Billion)
FIG. 19 Global Transdermal Patches Market Revenue, 2011-2019 (USD Billion)
FIG. 20 Global Other Drug Device Combination Products Market Revenue, 2011-2019 (USD Billion)
FIG. 21 Comparative Analysis: Global Drug Device Combination Products Market, by Geography
FIG. 22 North America Drug Device Combination Products Market Revenue, 2011-2019 (USD Billion)
FIG. 23 Europe Drug Device Combination Products Market Revenue, 2011-2019 (USD Billion)
FIG. 24 Asia-Pacific Drug Device Combination Products Market Revenue, 2011-2019 (USD Billion)
FIG. 25 RoW Drug Device Combination Products Market Revenue, 2011-2019 (USD Billion)
FIG. 26 Market Share Analysis: Global Drug Eluting Stents Market, by Key Players (2012)
FIG. 27 Market Share Analysis: Global Infusion Pumps Market, by Key Players (2012)
FIG. 28 Abbott Laboratories, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 29 Allergen, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 30 Alcon, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 31 Boston Scientific Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 32 CareFusion Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 33 Covidien PLC, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 34 C. R. Bard, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 35 Johnson & Johnson, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 36 Medtronic, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 37 Mylan, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 38 Stryker Corporation., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 39 Terumo Corporation., Annual Revenue: 2010 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Drug Device Combination Products Market
TABLE 2 Global Drug Device Combination Products Market, by Geography, 2011 - 2019 (USD Billion)

Enquiry Before Buying


Free Market Analysis


According to the U.S. Food and Drug Administration, drug device combination products are defined as therapeutic products comprising an active pharmaceutical ingredient and a medical device that are physically and/or chemically, combined to be produced as a single product. The drug present in the device may be impregnated or surface coated. Such products can be designed for local as well as systemic administration of drug to the patient. Recently, combination products are emerging as innovative medical products due to their contribution in advancing medical care and are thus expected to have major impact in the coming years.

Moreover, these products offer several advantages which include reduced adverse side effects, improved patient compliance, controlled release administration of drug, and also provide targeted drug delivery. The major product types in the market include drug eluting stents, infusion pumps, photosensitizers, orthopedic combination products, wound care combination products, inhalers, transdermal patches and others which include intraocular implants and drug eluting beads. Various emerging technologies such as implants with drugs to permit faster healing, relief from pain and decreased morbidity currently form the major driver for the growth of this market. The global drug device combination products market was valued at USD 66 billion in 2012 and is expected to grow at a CAGR of 7.9% from 2013 to 2019, to reach an estimated value of USD 115billion in 2019.

High incidence rates of chronic pain causing diseases, prostate cancer, diabetic retinopathy, cardiovascular diseases, colorectal cancer, asthma, obesity along with rapidly aging global population also form the key drivers for the global drug device combination products market. Government and NGO initiatives to promote drug delivery implants, rising number of interventional cardiologists and increase in the demand for minimally invasive surgeries are some of the other factors propelling the growth of the market. Introduction of biodegradable drug delivery technologies willserve as future growth opportunities for various drug device combination products. However, product recalls act as a major growth restraint for the market due to incidences such as adverse side effects to the patient. Also, these products form a challenge to FDA owing to their classification overlapping the regulated products and thus complicating their approval process.

Geographically, North America dominated the global drug device combination products market and is expected to continue to lead in terms of revenue generation throughout the forecast period. The market in North American region was valued at USD 28.5 billion in the year 2012.Asia-Pacific is considered as the most lucrative market for drug device combination products owing to the increase in incidences of cardiovascular diseases, diabetes related disorders and obesity through 2019. The leading players in the market for drug device combination products are Abbott Laboratories, Inc., Medtronic, Inc., Boston Scientific Corporation, CareFusion Corporation, Allergen, Inc. and others.

global-drug-device-combination-products-market-revenue-by-product-types-2012
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research